Symbol not found

NASDAQ:SVA   00:00AM GMT
0.00
0.00 (0.00%)
Products, Regulatory

Sinovac Receives Approval On Sabin Strain Based Inactivated Polio Vaccine (Sipv) To Support Global Polio Endgame Strategy

Published: 07/19/2021 13:02 GMT
Sinovac Biotech, Ltd. (SVA) - Sinovac Receives Approval on Sabin Strain Based Inactivated Polio Vaccine (sipv) to Support Global Polio Endgame Strategy.
Sinovac Biotech - Got Drug Registration Approval From National Medical Product Administration of China for Sabin Strain Based Inactivated Polio Vaccine.
Sinovac Biotech Ltd - Vaccine is Expected to Be Available on Market by End of 2021.